RxDoctor Payments Data

Nicholas Johnson, MD

Orthopaedic Surgery · Oklahoma City, OKNPI 1568966877

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (34.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Sanofi US Services Inc. at 35.5% of the total. Reporting peaked in 2024 at $19,004 and has fallen 95.9% since, to $773 in 2025.

$28,141in general payments, 2019–2025

Across 102 payments — averaging $275.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi US Services Inc.$10K
  • Smith+Nephew$9K
  • Stryker$3K
  • Peerless Surgical Inc.$2K
  • Medical Device Business Services, Inc.$1K
  • Encore Medical, LP$942
  • plus $2K from 10 others

What the payments were for

  • Consulting fees$9,65034%
  • Grants$1,8757%
  • Travel & lodging$6,60123%
  • Food & beverage$5,45219%
  • Education$4,56316%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,141 in reported general payments places this provider in the 80th percentile of 263 orthopaedic surgery providers in Oklahoma.

See all orthopaedic surgery providers in Oklahoma

Medicare billing

Part B allowed, 2024
$135,368
Medicare patients
259
Services billed
718

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron33$320
Cefadroxil14$225
Doxycycline Hyclate14$215
Oxycodone Hcl43$212
Hydroxyzine Pamoate15$179
Tramadol Hcl47$170
Famotidine30$136
Tranexamic Acid12$126
Methocarbamol14$98
Meloxicam28$87
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$77

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →